CBD Life Sciences, Inc. (CBDL) Releases Letter to Shareholders
By:
CBD Life Sciences Inc. via
AccessWire
January 26, 2022 at 07:00 AM EST
SCOTTSDALE, AZ / ACCESSWIRE / January 26, 2022 / Today CBD Life Sciences (OTC PINK:CBDL) through its wholly owned subsidiary, LBC Bioscience Inc. announces today that the company will be releasing a letter to its fellow shareholders. CBD Life Sciences Inc. has been sharpening its strategic focus in several ways and 2022 is going to be a big year for the company to say the least. The company has been looking into acquiring more locations for retail for quite some time now and finally there are a few spots that are in interest which is great news! Along with retail locations, CBD Life Sciences Inc. has been looking to purchase more vending machines to put into various locations across the United States. President & CEO Lisa Nelson states "After placing our first machine in Tanger Outlets located in Glendale, AZ, we have been seeing significant revenue generate, so this was sort of a test run before we start purchasing multiple machines." Lisa Nelson also stated, "Our team is currently in the process of locating a 20,000 sq ft indoor Hemp Facility for all of our needs as we are constantly expanding." Later in the upcoming months, CBD Life Sciences Inc. may have a possible partnership lined up with a company that has to do with cryptocurrency mining so that will be explosive if everything goes as planned. As far as the expansion of products in Europe goes, this will hopefully be all established this spring! Lastly, CBD Life Sciences Inc. would like to thank all of you for trusting the process and for remaining with the company as it grows into a thriving business with significant, long-term upside potential! The public will be informed regularly throughout all the topics discussed in this letter moving forward. The number of benefits CBD has is tremendous! These benefits may help with behavioral/neurological complications such as ADD/ADHD, anxiety, autism, bipolar, OCD, PTSD, epilepsy, Parkinson's, osteoporosis, and ALS. CBD may also benefit pain management that can stem from headaches/migraines, arthritis, cramps, spinal injuries, and fibromyalgia. CBD has been found to also have gastrointestinal benefits with gastro-disorders and complications such as anorexia, cachexia, Crohn's, diabetes, and nausea. Physical complications/disorders such as muscular dystrophy and even immune system-based deficiencies and other complications such as cancer and hypertension even our bodies way and ability to maintain homeostasis have all been said to benefit from CBD. LBC BIOSCIENCE INC. ONLINE STORE LBC BIOSCIENCE'S Online Emporium LBC Bioscience Inc. is well stocked already as it is with some very high-quality CBD offerings - all at very reasonable prices. Check out LBC Bioscience Inc's newest product offerings including its: 100MG CBD Bath Bombs in a variety of scents, Delta 8 Gummies, 1500 MG Premium Berry Drops, and a variety of all-new Skincare products. Or shop our top selling products (based on order frequency) which include our CBD Pain Cream, CBD Oils and CBD Pet Treats.
LBC Bioscience Inc. accepts: Visa, MasterCard, American Express, Discover etc. Shareholders and interest holders may also stay current with LBC Bioscience Inc Updates: LBC Bioscience Inc's Main Website at www.lbcbioscienceinc.com About LBC Bioscience Inc. Ten Associates LLC Forward-Looking Statements Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See CBD Life Sciences, Inc's, Inc.'s filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements. Safe Harbor Statement This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking SOURCE: CBD Life Sciences Inc. View source version on accesswire.com: https://www.accesswire.com/685481/CBD-Life-Sciences-Inc-CBDL-Releases-Letter-to-Shareholders More NewsView More
DoorDash’s Recent Stock Dip Equals 60% Upside ↗
Today 12:15 EST
Via MarketBeat
Tickers
DASH
Wall Street Loves Williams-Sonoma Right Now—Here’s Why the Stock Could Soar in 2026 ↗
Today 10:22 EST
Via MarketBeat
Tickers
WSM
Meta Wins FTC Fight, Keeps Instagram Growth Machine Intact ↗
Today 10:17 EST
Via MarketBeat
Tickers
META
Via MarketBeat
Tickers
SBUX
MP Materials Stock Soared After Earnings—Here’s the Real Reason ↗
November 22, 2025
Via MarketBeat
Recent QuotesView More
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
|